Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

GLORY Announces Plan to Acquire Revolution Retail Systems LLC: https://mms.businesswire.com/media/20200131005224/en/495440/5/glory_logo_rgb_large.jpg
GLORY Announces Plan to Acquire Revolution Retail Systems LLC


Glory Global Solutions Inc., a global leader in cash technology solutions, today announced it has made an offer to acquire Carrollton, TX based Revolution Retail Systems LLC (Revolution). Subject

GLORY Announces Plan to Acquire Revolution Retail Systems LLC: https://mms.businesswire.com/media/20200131005224/en/495440/5/glory_logo_rgb_large.jpg
GLORY Announces Plan to Acquire Revolution Retail Systems LLC


Glory Global Solutions Inc., a global leader in cash technology solutions, today announced it has made an offer to acquire Carrollton, TX based Revolution Retail Systems LLC (Revolution). Subject

Lysogene Secures a €4.3 Million Non-dilutive Financing From Bpifrance to Support Its Development
Lysogene Secures a €4.3 Million Non-dilutive Financing From Bpifrance to Support Its Development


Regulatory News:



Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announced today that it has secured a €4.3

Mannatech Declares Special 2021 Dividend: https://mms.businesswire.com/media/20210511005229/en/877334/5/logo-mannatech-schema.jpg
Mannatech Declares Special 2021 Dividend


Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend

GenSight Biologics to Host Key Opinion Leader Webcast on Outcomes Among Compassionate Use Patients Treated Bilaterally with LUMEVOQ® in the US: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics to Host Key Opinion Leader Webcast on Outcomes Among Compassionate Use Patients Treated Bilaterally with LUMEVOQ® in the US


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

Pulse Biosciences to Participate in the Stephens Annual Investment Conference: https://mms.businesswire.com/media/20211005005394/en/913083/5/pulse-logo.jpg
Pulse Biosciences to Participate in the Stephens Annual Investment Conference


Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced plans to

Granite REIT Declares Distribution for November 2021: https://mms.businesswire.com/media/20191217005844/en/763597/5/Granite_REIT_rgb.png.jpg
Granite REIT Declares Distribution for November 2021


Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CAD $0.250 per stapled unit for the month of

CI Global Asset Management Funds and ETFs Win 13 Refinitiv Lipper Fund Awards: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Global Asset Management Funds and ETFs Win 13 Refinitiv Lipper Fund Awards


CI Global Asset Management (“CI GAM”) announced today that its investment funds have been recognized with 13 Refinitiv Canada Lipper Fund Awards for 2021. The awards recognize funds that have

Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum


Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”)

GenSight Biologics Reports Second Patient Case Showing Significant Visual Recovery after GS030 Optogenetic Treatment: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics Reports Second Patient Case Showing Significant Visual Recovery after GS030 Optogenetic Treatment


GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative

Pulse Biosciences Reports Third Quarter 2021 Financial Results: https://mms.businesswire.com/media/20211005005394/en/913083/5/pulse-logo.jpg
Pulse Biosciences Reports Third Quarter 2021 Financial Results


Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced financial

 
GECI INTERNATIONAL : 2021-22 FIRST-HALF REVENUES
GECI INTERNATIONAL : 2021-22 FIRST-HALF REVENUES

GECI International, the Digital and Technology specialist, is reporting stable first-half revenues, in line with its target to return to profitability.

FIRST-HALF KEY DEVELOPMENTS


The Group's

CI Global Asset Management Announces November 2021 Distributions for CI ETFs: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Global Asset Management Announces November 2021 Distributions for CI ETFs


CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending November 30, 2021 in respect of CI ETFs. In all cases, the distribution will be paid on

Mannatech Reports Third Quarter End 2021 Financial Results: https://mms.businesswire.com/media/20210511005229/en/877334/5/logo-mannatech-schema.jpg
Mannatech Reports Third Quarter End 2021 Financial Results


Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2021.

GenSight Biologics to Present New Clinical Data of LUMEVOQ® and GS030 Gene Therapies at the American Academy of Ophthalmology 2021 Meeting: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics to Present New Clinical Data of LUMEVOQ® and GS030 Gene Therapies at the American Academy of Ophthalmology 2021 Meeting


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

CI Financial Reports Record Financial Results for the Third Quarter of 2021: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Financial Reports Record Financial Results for the Third Quarter of 2021


CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today released record financial results for the quarter ended September 30, 2021.



“It was another record financial quarter for CI and included a

CI Financial Reports Record Total Assets of $331.8 Billion for October 2021: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Financial Reports Record Total Assets of $331.8 Billion for October 2021


CI Financial Corp. (“CI”) (TSX:CIX, NYSE:CIXX) today reported preliminary assets under management as at October 31, 2021 of $150.2 billion and wealth management assets of $181.6 billion, for total

CI Financial Makes Strategic Investment in GLASfunds, a Leading Alternative Investment Platform: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Financial Makes Strategic Investment in GLASfunds, a Leading Alternative Investment Platform


CI Financial Corp. (“CI”) (TSX: CIX; NYSE: CIXX) announced today it has made a strategic investment in GLAS Funds, LLC (“GLASfunds™”), a turnkey alternative investment platform and alternative

CI Financial to Acquire Gofen and Glossberg, a US$7.5-Billion Chicago-Based RIA Serving High-Net-Worth Families: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Financial to Acquire Gofen and Glossberg, a US$7.5-Billion Chicago-Based RIA Serving High-Net-Worth Families


CI Financial Corp. (“CI”) (TSX:CIX; NYSE:CIXX) and Gofen and Glossberg, LLC (“Gofen”) today announced an agreement under which CI will acquire Gofen, a US$7.5-billion wealth and investment

Fuel Tech Reports 2021 Third Quarter Financial Results: https://mms.businesswire.com/media/20191104005760/en/446201/5/Fuel_Tech_Logo.jpg
Fuel Tech Reports 2021 Third Quarter Financial Results


Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control, and water treatment in utility and

SunLike Series Natural Spectrum LEDs von Seoul Semiconductor von der Produktinnovationsmarke biOrb ausgewählt
SunLike Series Natural Spectrum LEDs von Seoul Semiconductor von der Produktinnovationsmarke biOrb ausgewählt


Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), ein führender und weltweit tätiger Innovator im Bereich der LED-Technologie, gab bekannt, dass seine LEDs der SunLike-Serie mit natürlichem Spektrum

Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Selected by Product Innovation Brand biOrb
Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Selected by Product Innovation Brand biOrb


Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED technology, announced that its SunLike Series natural spectrum LEDs, which implement light that closely matches the

Granite Announces 2021 Third Quarter Results, $260 Million of New Acquisitions and Developments, and a 3.3% Distribution Increase Commencing December 2021
Granite Announces 2021 Third Quarter Results, $260 Million of New Acquisitions and Developments, and a 3.3% Distribution Increase Commencing December 2021


Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN; NYSE: GRP.U) (“Granite” or the “Trust”) announced today its combined results for the three and nine month periods ended

Granite Announces the Establishment of a $250 Million At-the-Market Equity Program: https://mms.businesswire.com/media/20191217005844/en/763597/5/Granite_REIT_rgb.png.jpg
Granite Announces the Establishment of a $250 Million At-the-Market Equity Program


Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN; NYSE: GRP.U) (“Granite” or the “Trust”) announced today the establishment of a $250 million at-the-market equity

Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021: https://mms.businesswire.com/media/20211005005394/en/913083/5/pulse-logo.jpg
Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021


Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, announced today it will report financial results for the third